Study: Medical Cannabis Products Provide Sustained Improvements in Patients With Chronic Pain, Anxiety, and Depression
Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The Independent Evidence WatchDaily Digest 2026-03-08 CED Clinic BlogCannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years
Left Exit 12 Off Ramp
Guessing your dose / Evidence-based titration Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The Independent Evidence WatchDaily Digest 2026-03-08 CED Clinic BlogCannabis-Infused Beverages as…
Endocannabinoid System & PTSD: Cannabis in Dual Diagnosis
Cannabis use and trauma-focused treatment are critical considerations in managing PTSD with co-occurring substance use disorders. Evidence shows trauma-focused treatments remain effective despite cannabis use. This supports continuing evidence-based care…
Exploring Endocannabinoid System Research in Digital Mental Health
This article discusses how endocannabinoid system research meets digital mental health through a randomized controlled trial of the Minder app. The study highlights cannabis-related mental health support for university students. Digital tools offer…
Medical Cannabis Evidence-Based Care: Phase 3 Trial Results
This phase 3 cannabis trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 in 820 adults. The trial demonstrated significant pain reduction over 12 weeks with sustained effects. These results provide important evidence…
Endocannabinoid System & Chronic Pain: Clinical Evidence Review
Clinical trials demonstrate cannabinoids for chronic pain clinical evidence with modest reductions in neuropathic and mixed pain. Benefits are often accompanied by adverse effects like dizziness and sedation. Patients and clinicians should weigh these…
In the Mix: 7 More Articles — March 02, 2026
Cannabis regulatory fragmentation continues to impact enforcement and market regulation in 2026. This article reviews recent cases highlighting legal ambiguities and product safety concerns. Understanding cannabis regulatory fragmentation is essential…
Daily Digest: Last 9 Hours: Cannabis and Anxiety Risk in the Long Run — March 02, 2026
This digest reviews a recent longitudinal study on cannabis and anxiety risk, emphasizing the dose-dependent relationship found. The evidence challenges the notion that cannabis reliably manages anxiety long-term. Clinical insights highlight the…
Cannabinoid Hyperemesis Syndrome: What Symptoms to Watch For
Cannabinoid hyperemesis syndrome symptoms include cyclical nausea, vomiting, and abdominal pain in chronic cannabis users. Early recognition of these symptoms is critical to avoid unnecessary interventions. Understanding cannabinoid hyperemesis syndrome…
New Study Reveals Cannabis-Anxiety Relationships and Clinical Implications
This decade-long study provides new evidence on 2026 cannabis anxiety clinical findings crucial for clinical counseling. It highlights increased anxiety risks linked to regular cannabis use. Clinicians should consider these findings when advising…
